Labiotech.eu

News and Trends 9 Apr 2019

French First-in-Class Diabetes Drug Nails Phase III Trial

An oral first-in-class drug targeting the mitochondria, developed by the French biotech Poxel, has shown big potential for treating type 2 diabetes in a phase III trial in Japan. Poxel’s lead candidate drug imeglimin has taken a step closer to entering the huge market for diabetes type 2 treatments. In a phase III trial in […]

April 9, 2019 - 3 minutesmins - By Jonathan Smith

In Depth 9 Apr 2019

Beyond the Lab-Grown Burger: ‘Cellular Agriculture’ is Taking Over the Food Industry

It’s been 6 years since scientists grew the world’s first beef burger made without the cow in the lab. As it nears its supermarket debut, researchers around the world are joining the cellular agriculture movement and growing all sorts of animal products, including delicacies such as foie gras and bluefin tuna, without the animal. As […]

April 9, 2019 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Apr 2019

AACR 2019: European Biotech Progresses in Fighting Cancer

The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the newest advances in cancer treatment from around the world. Sit back as we give you a quick rundown of the most interesting presentations from European organizations working to improve the treatment of cancer. Clinical trials In the conference last […]

April 8, 2019 - 4 minutesmins - By Jonathan Smith

Interview 8 Apr 2019

Francis Mojica, the Spanish Scientist Who Discovered CRISPR

Contrary to popular belief, Francis Mojica was the first person to discover the CRISPR mechanism and give it its name. He told me how the discovery came about, discussed the wide potential of the gene editing tool and shared his favorite CRISPR application. You’ve likely heard of CRISPR/Cas9, a gene editing tool that has taken […]

April 8, 2019 - 11 minutesmins - By Clara Rodríguez Fernández

Startup Scout 5 Apr 2019

This Biotech Is Making Tissue Bioprinting Child’s Play

3D printing living tissues is complex and technically tricky. Based in Gothenburg, Sweden, Cellink is developing bioprinting technology with a focus on making it easy to use for non-experts. Mission: To make bioprinting technology simpler to use for researchers. This could be used to make cancer disease models for drug testing, and even printing […]

April 5, 2019 - 4 minutesmins - By Jonathan Smith

GSK ViiV Healthcare Double HIV Treatment

News and Trends 4 Apr 2019

Update: Two-Drug HIV Treatment Effective for up to Three Years

Update (04/04/2019): ViiV Healthcare’s two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for up to three years in patients’ blood. In a clinical study, 513 HIV-infected people switched to daily pills of Juluca from their standard drug regimes, which included three or four different drugs. Juluca was effective at suppressing the virus for […]

April 4, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Lonza Chr Hansen Microbiome Manufacturing

News and Trends 3 Apr 2019

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

Lonza, a Swiss pharma supplier, and Chr. Hansen, a Danish supplier of bacterial products, are teaming up to enter the promising microbiome space. Together, the two companies will invest €90M in the creation of the first company that will offer a full supply chain to produce treatments made of live bacteria. Their 50/50 joint venture […]

April 3, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

chemical burns manchester cornea stem cells

News and Trends 3 Apr 2019

UK Scientists Activate Stem Cells to Heal Corneal Injuries

A group of researchers in the UK has developed a potential treatment for corneal injuries, such as those caused by chemical burns, by making surrounding tissue softer and letting stem cells regenerate damaged tissue. The cornea is a transparent tissue that is important for focusing light onto the retina and guarding entry into the eye. […]

April 3, 2019 - 2 minutesmins - By Jonathan Smith

More News! 3 Apr 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian investor V-Bio Ventures and Advent France Biotechnology. AgomAb will use the big Series A funding to test antibody treatments for fibrosis in clinical trials, as […]

April 3, 2019 - 2 minutesmins - By Jonathan Smith

Infographics 3 Apr 2019

Infographic: The Importance of New Biological Drug Characterization

By 2023, the monoclonal antibodies market is expected to reach a staggering $130B. The potential of monoclonal antibodies and other biologic drugs is huge. They are promising treatments for severe diseases and can improve or save patients’ lives. Check out our shiny new infographic on why these biologics need to be characterized properly! Download the […]

April 3, 2019 - 1 minutemin - By External Contributor

synbio genome artificial C eth2.0 bacteria 1

More News! 2 Apr 2019

Swiss Scientists Make Synthetic Bacterial Genome Using Computers

Synthetic biology researchers at ETH Zurich are the first to construct a simplified artificial bacterial genome with the help of computer algorithms, which could lead to better-engineered microorganisms for the production of therapeutics and other chemicals. Back in 2008, US researchers led by the famous biologist John Craig Venter made headlines for synthesizing the genome […]

April 2, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 2 Apr 2019

The 8 Best Biotech Companies in Europe’s History

We’ve put together a list of the best biotech companies in Europe to celebrate their invaluable contributions to science and the development of the booming industry that biotech is today. Though the beginnings of the biotech industry are commonly traced back to the US, Europe has stepped up as a major contender and ally in […]

April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

French First-in-Class Diabetes Drug Nails Phase III Trial

Beyond the Lab-Grown Burger: ‘Cellular Agriculture’ is Taking Over the Food Industry

AACR 2019: European Biotech Progresses in Fighting Cancer

Francis Mojica, the Spanish Scientist Who Discovered CRISPR

This Biotech Is Making Tissue Bioprinting Child’s Play

Update: Two-Drug HIV Treatment Effective for up to Three Years

Joint Venture First to Offer Seamless Manufacturing of Microbiome Therapies

UK Scientists Activate Stem Cells to Heal Corneal Injuries

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

Infographic: The Importance of New Biological Drug Characterization

Swiss Scientists Make Synthetic Bacterial Genome Using Computers

The 8 Best Biotech Companies in Europe’s History

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!